MedPath

Study on Polycystic ovary disease

Phase 3
Recruiting
Conditions
Health Condition 1: N830- Follicular cyst of ovary
Registration Number
CTRI/2023/10/058252
Lead Sponsor
Jayasree V
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age groups : 18yrs – 40yrs

Oligomenorrhoea (intermenstrual period of more than 35 days for 3 consecutive cycles/ amenorrhea for more than 3 months (2 years after menarche)

Ultrasound findings of polycystic ovaries.

Clinical evidence of hirsutism

Females who are diagnosed with PCOS

Exclusion Criteria

Pregnant women

Women using oral contraceptives or hormonal treatment

Women having irreversible pathological conditions like cancer

Cases with other systemic diseases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effectiveness of Homoepathic similimum in PCOSTimepoint: Baseline, 3 months and 6 months
Secondary Outcome Measures
NameTimeMethod
Will assess the effectiveness of 200C potency, USG findings and BMI scoreTimepoint: one year
© Copyright 2025. All Rights Reserved by MedPath